A citation-based method for searching scientific literature

Anne Marie McCarthy, Sarah Ehsan, Scott Appel, Michaela Welch, Wei He, Manisha Bahl, Jinbo Chen, Constance D Lehman, Katrina Armstrong. Cancer 2021
Times Cited: 2







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Combined effect of volumetric breast density and body mass index on breast cancer risk.
Natalie J Engmann, Christopher G Scott, Matthew R Jensen, Stacey Winham, Diana L Miglioretti, Lin Ma, Kathleen Brandt, Amir Mahmoudzadeh, Dana H Whaley, Carrie Hruska,[...]. Breast Cancer Res Treat 2019
12
100

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
Jeffrey A Tice, Steven R Cummings, Rebecca Smith-Bindman, Laura Ichikawa, William E Barlow, Karla Kerlikowske. Ann Intern Med 2008
349
100

Obesity, mammography use and accuracy, and advanced breast cancer risk.
Karla Kerlikowske, Rod Walker, Diana L Miglioretti, Arati Desai, Rachel Ballard-Barbash, Diana S M Buist. J Natl Cancer Inst 2008
64
100

Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
Anne Marie McCarthy, Zoe Guan, Michaela Welch, Molly E Griffin, Dorothy A Sippo, Zhengyi Deng, Suzanne B Coopey, Ahmet Acar, Alan Semine, Giovanni Parmigiani,[...]. J Natl Cancer Inst 2020
22
100

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
100

Validation of the breast cancer surveillance consortium model of breast cancer risk.
Jeffrey A Tice, Michael C S Bissell, Diana L Miglioretti, Charlotte C Gard, Garth H Rauscher, Firas M Dabbous, Karla Kerlikowske. Breast Cancer Res Treat 2019
26
50

Comparisons of two breast cancer risk estimates in women with a family history of breast cancer.
A McTiernan, A Kuniyuki, Y Yasui, D Bowen, W Burke, J B Culver, R Anderson, S Durfy. Cancer Epidemiol Biomarkers Prev 2001
50
50

Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women.
Rayna K Matsuno, Joseph P Costantino, Regina G Ziegler, Garnet L Anderson, Huilin Li, David Pee, Mitchell H Gail. J Natl Cancer Inst 2011
97
50

Diagnostic accuracy of the Gail model in the Black Women's Health Study.
Lucile L Adams-Campbell, Kepher H Makambi, Julie R Palmer, Lynn Rosenberg. Breast J 2007
23
50

pROC: an open-source package for R and S+ to analyze and compare ROC curves.
Xavier Robin, Natacha Turck, Alexandre Hainard, Natalia Tiberti, Frédérique Lisacek, Jean-Charles Sanchez, Markus Müller. BMC Bioinformatics 2011
50

Risk prediction models of breast cancer: a systematic review of model performances.
Thunyarat Anothaisintawee, Yot Teerawattananon, Chollathip Wiratkapun, Vijj Kasamesup, Ammarin Thakkinstian. Breast Cancer Res Treat 2012
72
50

Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Rowan T Chlebowski, Garnet L Anderson, Dorothy S Lane, Aaron K Aragaki, Thomas Rohan, Shagufta Yasmeen, Gloria Sarto, Carol A Rosenberg, F Allan Hubbell. J Natl Cancer Inst 2007
94
50

Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
Anne S Quante, Alice S Whittemore, Tom Shriver, Konstantin Strauch, Mary B Terry. Breast Cancer Res 2012
71
50

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. JAMA 2006
50

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
D A Berry, G Parmigiani, J Sanchez, J Schildkraut, E Winer. J Natl Cancer Inst 1997
259
50


Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.
E Amir, D G Evans, A Shenton, F Lalloo, A Moran, C Boggis, M Wilson, A Howell. J Med Genet 2003
186
50

US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Nadia Howlader, Sean F Altekruse, Christopher I Li, Vivien W Chen, Christina A Clarke, Lynn A G Ries, Kathleen A Cronin. J Natl Cancer Inst 2014
663
50

Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
Adam R Brentnall, Elaine F Harkness, Susan M Astley, Louise S Donnelly, Paula Stavrinos, Sarah Sampson, Lynne Fox, Jamie C Sergeant, Michelle N Harvie, Mary Wilson,[...]. Breast Cancer Res 2015
111
50

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
50

Projecting individualized absolute invasive breast cancer risk in African American women.
Mitchell H Gail, Joseph P Costantino, David Pee, Melissa Bondy, Lisa Newman, Mano Selvan, Garnet L Anderson, Kathleen E Malone, Polly A Marchbanks, Worta McCaskill-Stevens,[...]. J Natl Cancer Inst 2007
196
50

Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.
Jessica A Cintolo-Gonzalez, Danielle Braun, Amanda L Blackford, Emanuele Mazzola, Ahmet Acar, Jennifer K Plichta, Molly Griffin, Kevin S Hughes. Breast Cancer Res Treat 2017
80
50

A systematic review and quality assessment of individualised breast cancer risk prediction models.
Javier Louro, Margarita Posso, Michele Hilton Boon, Marta Román, Laia Domingo, Xavier Castells, María Sala. Br J Cancer 2019
45
50

Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data.
Dimitrios Zardavas, Luc Te Marvelde, Roger L Milne, Debora Fumagalli, George Fountzilas, Vassiliki Kotoula, Evangelia Razis, George Papaxoinis, Heikki Joensuu, Mary Ellen Moynahan,[...]. J Clin Oncol 2018
57
50

Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
Adam R Brentnall, Jack Cuzick, Diana S M Buist, Erin J Aiello Bowles. JAMA Oncol 2018
90
50

Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries.
Amber N Hurson, Parichoy Pal Choudhury, Chi Gao, Anika Hüsing, Mikael Eriksson, Min Shi, Michael E Jones, D Gareth R Evans, Roger L Milne, Mia M Gaudet,[...]. Int J Epidemiol 2021
6
50

Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries.
Amber N Hurson, Parichoy Pal Choudhury, Chi Gao, Anika Hüsing, Mikael Eriksson, Min Shi, Michael E Jones, D Gareth R Evans, Roger L Milne, Mia M Gaudet,[...]. Int J Epidemiol 2022
3
50

Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study.
Brian L Sprague, Emily F Conant, Tracy Onega, Michael P Garcia, Elisabeth F Beaber, Sally D Herschorn, Constance D Lehman, Anna N A Tosteson, Ronilda Lacson, Mitchell D Schnall,[...]. Ann Intern Med 2016
91
50

Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates.
Amanda I Phipps, Laura Ichikawa, Erin J A Bowles, Patricia A Carney, Karla Kerlikowske, Diana L Miglioretti, Diana S M Buist. Maturitas 2010
84
50

Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.
Matthew P Banegas, Esther M John, Martha L Slattery, Scarlett Lin Gomez, Mandi Yu, Andrea Z LaCroix, David Pee, Rowan T Chlebowski, Lisa M Hines, Cynthia A Thompson,[...]. J Natl Cancer Inst 2016
26
50

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
50

10-year performance of four models of breast cancer risk: a validation study.
Mary Beth Terry, Yuyan Liao, Alice S Whittemore, Nicole Leoce, Richard Buchsbaum, Nur Zeinomar, Gillian S Dite, Wendy K Chung, Julia A Knight, Melissa C Southey,[...]. Lancet Oncol 2019
72
50

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.
B Rockhill, D Spiegelman, C Byrne, D J Hunter, G A Colditz. J Natl Cancer Inst 2001
422
50

Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry.
Gillian S Dite, Robert J MacInnis, Adrian Bickerstaffe, James G Dowty, Richard Allman, Carmel Apicella, Roger L Milne, Helen Tsimiklis, Kelly-Anne Phillips, Graham G Giles,[...]. Cancer Epidemiol Biomarkers Prev 2016
65
50

Identifying women with dense breasts at high risk for interval cancer: a cohort study.
Karla Kerlikowske, Weiwei Zhu, Anna N A Tosteson, Brian L Sprague, Jeffrey A Tice, Constance D Lehman, Diana L Miglioretti. Ann Intern Med 2015
149
50


Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.
Karla Kerlikowske, Andrea J Cook, Diana S M Buist, Steve R Cummings, Celine Vachon, Pamela Vacek, Diana L Miglioretti. J Clin Oncol 2010
142
50

Imputing missing covariate values for the Cox model.
Ian R White, Patrick Royston. Stat Med 2009
523
50

Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
Karla Kerlikowske, Weiwei Zhu, Rebecca A Hubbard, Berta Geller, Kim Dittus, Dejana Braithwaite, Karen J Wernli, Diana L Miglioretti, Ellen S O'Meara. JAMA Intern Med 2013
134
50

Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes.
Rebecca A Hubbard, Theodora M Ripping, Jessica Chubak, Mireille J M Broeders, Diana L Miglioretti. Cancer Epidemiol Biomarkers Prev 2016
7
50

Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer.
Anna Weiss, Mariana Chavez-MacGregor, Daphne Y Lichtensztajn, Min Yi, Audree Tadros, Gabriel N Hortobagyi, Sharon H Giordano, Kelly K Hunt, Elizabeth A Mittendorf. JAMA Oncol 2018
103
50

Modelling the cumulative risk of a false-positive screening test.
Rebecca A Hubbard, Diana L Miglioretti, Robert A Smith. Stat Methods Med Res 2010
35
50

Mammography screening: A major issue in medicine.
Philippe Autier, Mathieu Boniol. Eur J Cancer 2018
54
50

Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort.
Robert J MacInnis, Julia A Knight, Wendy K Chung, Roger L Milne, Alice S Whittemore, Richard Buchsbaum, Yuyan Liao, Nur Zeinomar, Gillian S Dite, Melissa C Southey,[...]. J Natl Cancer Inst 2021
7
50

Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers.
Louise M Henderson, Diana L Miglioretti, Karla Kerlikowske, Karen J Wernli, Brian L Sprague, Constance D Lehman. AJR Am J Roentgenol 2015
25
50

Influence of breast density on breast cancer risk: a case control study in Japanese women.
Keiko Nishiyama, Naruto Taira, Taeko Mizoo, Mariko Kochi, Hirokuni Ikeda, Takayuki Iwamoto, Tadahiko Shien, Hiroyoshi Doihara, Setuko Ishihara, Hiroshi Kawai,[...]. Breast Cancer 2020
5
50

Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.
Ester Vilaprinyo, Carles Forné, Misericordia Carles, Maria Sala, Roger Pla, Xavier Castells, Laia Domingo, Montserrat Rue. PLoS One 2014
90
50

Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
Amy Trentham-Dietz, Karla Kerlikowske, Natasha K Stout, Diana L Miglioretti, Clyde B Schechter, Mehmet Ali Ergun, Jeroen J van den Broek, Oguzhan Alagoz, Brian L Sprague, Nicolien T van Ravesteyn,[...]. Ann Intern Med 2016
71
50


Nationwide cross-sectional adherence to mammography screening guidelines: national behavioral risk factor surveillance system survey results.
Anand Narayan, Alexander Fischer, Zihe Zhang, Ryan Woods, Elizabeth Morris, Susan Harvey. Breast Cancer Res Treat 2017
28
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.